Corteva (CTVA)
NYSE: CTVA · Fertilizers & Agricultural Chemicals · Indianapolis, IN
Our rating: Neutral
Call changed from Positive to Neutral at $8.12, moderate conviction, November 19, 2026.
Breaks if: The Neutral call turns Cautious if Corteva's next annual net margin falls below 5%, signaling that generic competition is structurally impounding the crop-protection franchise rather than cyclically compressing it. It turns Positive if the next two annual filings both show net margin at or above 9%, confirming the pricing environment has genuinely turned and the 5× multiple understates through-cycle earning power.
Key figures
| Market value | $5.3B |
|---|---|
| Revenue, last 12 months | $17.7B |
| Net income, last 12 months | $759M |
| Free cash flow, last 12 months | −$149M |
| Price to earnings | 6.9× |
| Free cash flow yield | −2.8% |
| Dividend yield | 1.4% |
| Operating margin | n/a |
| Return on equity | 3.1% |
| Beta to the S&P 500 | 0.51 |
| Volatility, annualized | 32.5% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $2.5B | −6.1% | $-0.85 | −$742M |
| June 30, 2026 | $6.4B | −1.2% | $1.73 | −$588M |
| March 31, 2026 | $4.9B | 11.0% | $1.07 | −$3.0B |
| December 31, 2025 | $3.9B | −1.7% | $-0.81 | $4.2B |
| September 30, 2025 | $2.6B | 12.6% | $-0.47 | $36M |
| June 30, 2025 | $6.5B | 5.6% | $1.92 | $829M |
| March 31, 2025 | $4.4B | −1.7% | $0.95 | −$2.2B |
| December 31, 2024 | $4.0B | 7.3% | $-0.05 | $4.0B |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $3.93B: Claude 38%, Gemini 30%, Mistral 52%
- Diluted earnings per share are above zero: Claude 28%, Gemini 10%, Mistral 20%
- Free cash flow for the quarter is at least $4.15B: Claude 35%, Gemini 85%, Mistral 42%
- Backlog at the end of the quarter is at least $0.16B: Claude 45%, Gemini 90%, Mistral 50%
23 ledger entries and 30 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.